HomeCompareSCTL vs QYLD

SCTL vs QYLD: Dividend Comparison 2026

SCTL yields 181.82% · QYLD yields 12.24%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SCTL wins by $69.49M in total portfolio value
10 years
SCTL
SCTL
● Live price
181.82%
Share price
$1.10
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$69.51M
Annual income
$33,388,080.18
Full SCTL calculator →
QYLD
Global X Nasdaq 100 Covered Call ETF
● Live price
12.24%
Share price
$16.70
Annual div
$2.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.5K
Annual income
$6,038.84
Full QYLD calculator →

Portfolio growth — SCTL vs QYLD

📍 SCTL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSCTLQYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SCTL + QYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SCTL pays
QYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SCTL
Annual income on $10K today (after 15% tax)
$15,454.55/yr
After 10yr DRIP, annual income (after tax)
$28,379,868.15/yr
QYLD
Annual income on $10K today (after 15% tax)
$1,040.82/yr
After 10yr DRIP, annual income (after tax)
$5,133.01/yr
At 15% tax rate, SCTL beats the other by $28,374,735.14/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SCTL + QYLD for your $10,000?

SCTL: 50%QYLD: 50%
100% QYLD50/50100% SCTL
Portfolio after 10yr
$34.77M
Annual income
$16,697,059.51/yr
Blended yield
48.02%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SCTL right now

SCTL
Analyst Ratings
4
Buy
3
Hold
Consensus: Buy
Altman Z
-1.3
Piotroski
4/9
QYLD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SCTL buys
0
QYLD buys
0
No recent congressional trades found for SCTL or QYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSCTLQYLD
Forward yield181.82%12.24%
Annual dividend / share$2.00$2.04
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$69.51M$26.5K
Annual income after 10y$33,388,080.18$6,038.84
Total dividends collected$65.15M$28.5K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: SCTL vs QYLD ($10,000, DRIP)

YearSCTL PortfolioSCTL Income/yrQYLD PortfolioQYLD Income/yrGap
1← crossover$28,882$18,181.82$10,384$1,224.49+$18.5KSCTL
2$79,981$49,077.01$10,900$1,388.18+$69.1KSCTL
3$212,594$127,014.75$11,576$1,590.76+$201.0KSCTL
4$543,003$315,527.24$12,447$1,844.20+$530.6KSCTL
5$1,334,202$753,189.45$13,567$2,164.97+$1.32MSCTL
6$3,157,175$1,729,577.94$15,003$2,576.05+$3.14MSCTL
7$7,203,193$3,825,015.79$16,853$3,110.04+$7.19MSCTL
8$15,863,391$8,155,975.05$19,251$3,813.85+$15.84MSCTL
9$33,760,443$16,786,614.57$22,390$4,756.08+$33.74MSCTL
10$69,511,754$33,388,080.18$26,548$6,038.84+$69.49MSCTL

SCTL vs QYLD: Complete Analysis 2026

SCTLStock

Societal CDMO, Inc., a contract development and manufacturing organization, engages in the research and development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market. The company was formerly known as Recro Pharma, Inc. and changed its name to Societal CDMO, Inc. in March 2022. Societal CDMO, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.

Full SCTL Calculator →

QYLDETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →
📬

Get this SCTL vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SCTL vs SCHDSCTL vs JEPISCTL vs OSCTL vs KOSCTL vs MAINSCTL vs XYLDSCTL vs JEPQSCTL vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.